GDF15 and cancer: The NAG-1 expression levels substantially increase in cancer cells, serum, and/or cerebrospinal fluid during the progression of diverse human aggressive cancers, such as intracranial brain tumors, melanoma, gastrointestinal, pancreatic, colorectal, prostate, breast, and lung epithelial cancers.